What's in a Name? Cell Fate Reprogramming in Sarcomagenesis
- PMID: 29316432
- DOI: 10.1016/j.ccell.2017.12.005
What's in a Name? Cell Fate Reprogramming in Sarcomagenesis
Abstract
Differentiation features in cancer cells are typically attributed to the cell of origin. In this issue of Cancer Cell, Drummond et al. demonstrate a transdifferentiation program apparent in rhabdomyosarcomas (cancers with skeletal muscle differentiation features) arising through cell fate reprogramming from a single oncogene activation in endothelial cell precursors.
Copyright © 2017 Elsevier Inc. All rights reserved.
Comment on
-
Hedgehog Pathway Drives Fusion-Negative Rhabdomyosarcoma Initiated From Non-myogenic Endothelial Progenitors.Cancer Cell. 2018 Jan 8;33(1):108-124.e5. doi: 10.1016/j.ccell.2017.12.001. Cancer Cell. 2018. PMID: 29316425 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
